Pain Management in Florida: Prescribing Rules, Clinics, and Penalties

Florida pain management laws set some of the strictest opioid prescribing rules in the country. A prescription for a Schedule II opioid to treat acute pain generally cannot exceed a three-day supply, prescribers must check the state’s prescription drug monitoring database before writing any controlled substance prescription for a patient 16 or older, and any clinic that advertises pain management or primarily prescribes opioids for chronic non-cancer pain has to register with the Department of Health. The rules layer on top of federal DEA requirements, and violations can end a license.

The Three-Day Limit on Acute Pain Prescriptions

Florida’s tightest cap targets acute pain, meaning short-term pain following surgery, an injury, or an illness. A prescription for a Schedule II opioid to treat acute pain cannot exceed a three-day supply.¹

A prescriber can extend that to a seven-day supply, but only if all three of these conditions are met:

The prescriber’s professional judgment is that more than three days is medically necessary for the acute condition.
The prescription is marked with the notation “ACUTE PAIN EXCEPTION.”
The medical record documents the specific condition and explains why alternative treatments are inadequate.

The three-day default with a seven-day ceiling applies specifically to Schedule II opioids for acute pain. It does not apply to chronic pain treatment, cancer pain, palliative care, or patients in a long-term care facility. Prescribers who ignore these limits face disciplinary action under Florida’s practitioner discipline statute.¹

Prescribing Standards for Chronic Non-Cancer Pain

Chronic non-cancer pain, defined in Florida law as pain that persists beyond the normal course of a disease or injury or more than 90 days after surgery, triggers a much longer list of obligations. This is where the state’s rules go well past writing a prescription and scheduling a follow-up.

Initial Evaluation

Before prescribing any controlled substance for chronic non-cancer pain, the provider must conduct and document a thorough evaluation. At a minimum, that includes the nature and intensity of the pain, current and past pain treatments, any coexisting diseases, how the pain affects daily functioning, a review of prior medical records and diagnostic studies, and a history of alcohol and substance use. The record must also document at least one recognized medical indication for using a controlled substance.¹ The evaluation has to happen before treatment begins, not after.

Written Treatment Plan and Risk Assessment

Each patient must have a written individualized treatment plan setting specific objectives, such as measurable improvements in pain relief and physical or psychological functioning, and noting any additional diagnostic testing or other treatments planned. Separately, the prescriber must develop a written plan for assessing the patient’s risk of problematic drug-related behavior. That risk assessment can include drug testing and must be applied on an ongoing basis throughout treatment.¹

Ongoing Monitoring

Patients on long-term controlled substance therapy must be seen at regular intervals no longer than three months apart. At each visit, the prescriber evaluates whether the current treatment is working, whether controlled substances remain appropriate, whether the patient is making progress toward the plan’s goals, and whether any adverse drug effects have developed.¹

Referral When Substance Abuse Appears

If a patient shows signs of substance abuse, Florida law requires immediate referral to a board-certified pain management physician, an addiction medicine specialist, or a mental health addiction facility. The one exception is a prescriber already board-certified or board-eligible in pain management. While waiting for the consultant’s assessment, the prescriber must thoroughly document the medical justification for continuing controlled substance treatment and the steps taken to prevent misuse.¹

Controlled Substance Agreements With Patients

Before ongoing controlled substance therapy begins, the prescriber and patient must sign a written controlled substance agreement. It defines the ground rules for the treatment relationship and creates enforceable expectations on both sides.

The agreement must cover at least three things: how many prescriptions and refills the patient will receive and how often, the specific circumstances under which the provider can discontinue treatment (such as violating the agreement), and a commitment that the patient will receive controlled substances for chronic non-cancer pain from only one prescriber unless the treating provider authorizes an exception in writing.¹

Many providers add terms beyond the statutory minimum, such as requiring use of a single pharmacy, refusing to replace lost or stolen medications, and consenting to periodic drug testing. The statute authorizes drug testing as part of the risk assessment plan, and most pain management practices treat it as standard. Refusing a drug test or testing positive for unauthorized substances is commonly treated as a violation of the agreement and can lead to discharge from the practice.

Checking E-FORCSE Before Prescribing

Florida’s Prescription Drug Monitoring Program, called E-FORCSE (Electronic-Florida Online Reporting of Controlled Substance Evaluation), is a statewide database that tracks every controlled substance dispensed in the state. It was created in 2009 and covers Schedules II through V.²

Before writing a prescription for any controlled substance in Schedules II through V for a patient aged 16 or older, the prescriber or an authorized designee must check E-FORCSE to review the patient’s dispensing history.³ The check is mandatory every time, not just for new patients. Pharmacies and other dispensers must report each dispensing event to E-FORCSE no later than the close of business the next day, which keeps the database current enough to be useful for the next prescriber who checks it.²

A prescriber or dispenser who fails to consult E-FORCSE as required receives a non-disciplinary citation for a first offense. That’s essentially a formal warning. Any subsequent failure triggers actual disciplinary proceedings against the practitioner’s license.²

Access to E-FORCSE records is limited. Prescribers and dispensers can access the system for treatment. Law enforcement agencies can access records in connection with active investigations conducted with a good-faith belief that the investigation could lead to administrative, civil, or criminal proceedings. Health care regulatory boards can access the data for oversight, and patients can request their own records.³

Telehealth Limits on Schedule II Opioids

Florida places significant limits on prescribing controlled substances through telehealth. A telehealth provider cannot prescribe a Schedule II controlled substance via telehealth except in narrow circumstances: treatment of a psychiatric disorder, inpatient hospital treatment, hospice care, or care of a nursing home resident.⁴ For most outpatient pain management patients, this effectively means Schedule II opioids require an in-person visit.

At the federal level, the DEA and HHS have extended COVID-era telehealth flexibilities through December 31, 2026, which technically allow DEA-registered practitioners to prescribe Schedule II through V controlled substances via telehealth without a prior in-person evaluation.⁵ Florida’s state-level restriction is stricter than the federal rule, and the stricter standard controls. In practice, the state’s narrow exceptions are what matters for Schedule II drugs.

Pain Management Clinic Registration

Any facility in Florida that advertises pain management services, or where most patients in a given month receive prescriptions for opioids, benzodiazepines, barbiturates, or carisoprodol to treat chronic non-cancer pain, must register with the Department of Health.⁶ Each physical location needs its own separate registration, even if multiple clinics share the same owner or business name.

Who Can Own a Pain Clinic

Ownership is restricted. A registered pain management clinic must be fully owned by one or more physicians licensed in Florida, or it must be licensed as a health care clinic through the Agency for Health Care Administration.⁷ A non-physician investor or business entity that doesn’t meet one of these paths cannot own a pain clinic in the state.

Designated Physician

Every registered clinic must name a designated physician who takes personal legal responsibility for compliance. That physician must hold a full, active, and unencumbered Florida medical license and must actually practice at the clinic location. You can’t designate someone who works elsewhere.⁸

Exemptions From Registration

Several categories of facilities are exempt from full registration, though they must still apply for a certificate of exemption from the Department of Health. Exempt facilities include:

Licensed hospitals and hospital-based clinics operating under Chapter 395
Surgical practices where most physicians on staff primarily perform surgery
Large publicly held corporations whose shares trade on a national exchange and whose total assets exceed $50 million
Clinics affiliated with accredited medical schools that train students, residents, or fellows
Clinics that don’t prescribe controlled substances for pain
Tax-exempt nonprofits organized under 26 U.S.C. §501(c)(3)
Specialty practices wholly owned and operated by board-eligible or board-certified anesthesiologists, physiatrists, rheumatologists, or neurologists

The exemption certificate still requires a formal application.⁶

Unannounced Inspections

Registered clinics face unannounced annual inspections by the Department of Health. During an inspection, the department reviews a random selection of patient records for each physician who has practiced at the clinic within the past six months. Clinics that hold current accreditation from a nationally recognized accrediting agency approved by the Board of Medicine can notify the department and may satisfy the inspection requirement through that accreditation instead.⁹

What Must Be in the Medical Record

Florida’s documentation standards for chronic non-cancer pain patients are unusually specific. Each medical record must include, at a minimum:

A complete history and physical, including any history of drug or alcohol dependence
Diagnostic and lab results relevant to the pain condition
The treatment objectives from the individualized plan
Documented evidence that the provider discussed risks and benefits with the patient
The date, type, dosage, and quantity of every controlled substance prescribed
Results from any drug testing
A photocopy of the patient’s government-issued photo ID
A copy of any written prescription given to the patient

Records must be accurate, current, complete, and readily accessible for review at all times.¹ Because the Department of Health inspects unannounced and pulls random files, sloppy recordkeeping is one of the fastest ways for a clinic to end up in regulatory trouble.

Penalties for Violations

Enforcement runs on two tracks that stack on top of each other.

State License Discipline

A prescriber who fails to follow Florida’s acute pain guidelines faces disciplinary action through the applicable licensing board. The statute explicitly treats non-compliance as grounds for discipline.¹ Depending on severity, sanctions can range from fines and mandatory education to license suspension or revocation. The same disciplinary framework covers chronic pain violations, including failure to conduct proper evaluations, failure to maintain treatment plans, and failure to refer patients showing signs of substance abuse. For clinics, operating without proper registration is treated as a serious violation, and the Department of Health can impose per-violation fines and revoke registrations for repeated non-compliance.

Federal Recordkeeping Penalties

Clinics that fail to maintain accurate controlled substance records also face federal exposure. Under federal law, negligently failing to keep required records can result in civil penalties of up to $10,000 per violation. If the failure is knowing rather than negligent, criminal penalties apply: up to one year in prison for a first offense, and up to two years for repeat offenders.¹⁰ These federal penalties sit alongside any state consequences, so one recordkeeping failure can trigger enforcement from more than one direction.

Prescriber Training Obligations

Florida prescribers carry both state and federal training requirements tied to controlled substances.

Florida’s Biennial Continuing Education

Any prescriber registered with the DEA and authorized to prescribe controlled substances must complete a two-hour, board-approved continuing education course on controlled substance prescribing as part of each biennial license renewal.¹¹ The course must be offered by a statewide professional association accredited for AMA or AOA continuing education credits, and proof of completion goes in with the renewal application.

Federal MATE Act Training

Since June 2023, the federal Mainstreaming Addiction Treatment (MATE) Act has required all practitioners applying for a new or renewed DEA registration to attest to completing at least eight hours of training on opioid and other substance use disorders. The training must cover treatment and management of patients with substance use disorders and the appropriate use of FDA-approved medications for treating those disorders.¹²

Practitioners can also satisfy the requirement by holding a current board certification in addiction medicine or addiction psychiatry, or by having graduated within the past five years from a qualifying medical, nurse practitioner, or physician assistant program that included substance use disorder training. The eight hours can be accumulated over time rather than completed in one sitting.

1
The Florida Legislature. Florida Statutes 456.44 – Controlled Substance Prescribing
2
Florida Department of Health. Prescription Drug Monitoring Program – Take Control of Controlled Substances
3
The Florida Legislature. Florida Statutes 893.055 – Prescription Drug Monitoring Program
4
The Florida Legislature. Florida Statutes 456.47 – Telehealth
5
Federal Register. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
6
The Florida Legislature. Florida Statutes 458.3265 – Pain-Management Clinics
7
Florida Department of Health. Pain Management Clinics
8
The Florida Legislature. Florida Statutes 459.0137 – Pain-Management Clinics
9
Cornell Law Institute. Florida Admin Code 64B8-9.0132 – Requirement for Pain Management Clinic Inspections
10
Office of the Law Revision Counsel. 21 USC Chapter 13, Subchapter I, Part D – Offenses and Penalties
11
The Florida Legislature. Florida Statutes 456.0301 – Requirement for Instruction on Controlled Substance Prescribing
12
Substance Abuse and Mental Health Services Administration. Training Requirements (MATE Act) Resources